Assignee
VERACYTE INC
US·16 granted patents·41 pending applications·150 citations·filing 2012–2025
Top patents by PatentIndex Score
57 records- 0198US10731223B2Algorithms for disease diagnosticsVERACYTE INC·Filed 2017·Granted Aug 4, 2020·26 cites·17 claims
- 0298US10236078B2Methods for processing or analyzing a sample of thyroid tissueVERACYTE INC·Filed 2017·Granted Mar 19, 2019·16 cites·29 claims
- 0398US9856537B2Algorithms for disease diagnosticsVERACYTE INC·Filed 2016·Granted Jan 2, 2018·27 cites·24 claims
- 0497US10114924B2Methods for processing or analyzing sample of thyroid tissueVERACYTE INC·Filed 2017·Granted Oct 30, 2018·24 cites·30 claims
- 0595US12110554B2Methods for classification of tissue samples as positive or negative for cancerVERACYTE INC·Filed 2021·Granted Oct 8, 2024·3 cites·21 claims
- 0695US10672504B2Algorithms for disease diagnosticsVERACYTE INC·Filed 2019·Granted Jun 2, 2020·15 cites·21 claims
- 0795US10446272B2Methods and compositions for classification of samplesVERACYTE INC·Filed 2017·Granted Oct 15, 2019·15 cites·22 claims
- 0892US12305238B2Methods for treatment of thyroid cancerVERACYTE INC·Filed 2024·Granted May 20, 2025·0 cites·28 claims
- 0990US10934587B2Methods and compositions for diagnosis of thyroid conditionsVERACYTE INC·Filed 2014·Granted Mar 2, 2021·6 cites·17 claims
- 1089US11217329B1Methods and systems for determining biological sample integrityVERACYTE INC·Filed 2018·Granted Jan 4, 2022·7 cites·19 claims
- 1188US12297503B2Methods for classification of tissue samples as positive or negative for cancerVERACYTE INC·Filed 2024·Granted May 13, 2025·0 cites·30 claims
- 1285US10526655B2Methods for evaluating COPD statusVERACYTE INC·Filed 2014·Granted Jan 7, 2020·9 cites·12 claims
- 1385US2025037869A1Methods and compositions for classification of samplesVERACYTE INC·Filed 2024·Application pending·0 cites
- 1484US11639527B2Methods for nucleic acid sequencingVERACYTE INC·Filed 2021·Granted May 2, 2023·1 cites·16 claims
- 1583US11976329B2Methods and systems for detecting usual interstitial pneumoniaVERACYTE INC·Filed 2021·Granted May 7, 2024·1 cites·20 claims
- 1679US12534763B2Systems and methods of diagnosing idiopathic pulmonary fibrosisVERACYTE INC·Filed 2023·Granted Jan 27, 2026·0 cites·25 claims
- 1779US2025171854A1Genetic signatures to predict prostate cancer metastasis and identify tumor aggressivenessVERACYTE INC·Filed 2024·Application pending·0 cites
- 1874US2023272476A1Nano46 genes and methods to predict breast cancer outcomeVERACYTE INC·Filed 2022·Application pending·0 cites
- 1974US2024417800A1Use of a genetic signature diagnostically to evaluate treatment strategies for prostate cancerVERACYTE INC·Filed 2024·Application pending·0 cites
- 2074US2020202974A1Algorithms for disease diagnosticsVERACYTE INC·Filed 2020·Application pending·0 cites
- 2173US2019172551A1Algorithms for disease diagnosticsVERACYTE INC·Filed 2019·Application pending·0 cites
- 2272US2019080047A1Algorithms for disease diagnosticsVERACYTE INC·Filed 2018·Application pending·0 cites
- 2372US2020176078A1Algorithms for disease diagnosticsVERACYTE INC·Filed 2020·Application pending·0 cites
- 2469US2021332431A1Methods for nucleic acid sequencingVERACYTE INC·Filed 2021·Application pending·0 cites
- 2567US2014378425A1Biomarkers for diagnosis of lung diseases and methods of use thereofVERACYTE INC·Filed 2014·Application pending·0 cites
- 2667US2020143944A1Methods and compositions for classification of samplesVERACYTE INC·Filed 2019·Application pending·0 cites
- 2766US2021040559A1Biomarkers for diagnosis of lung diseases and methods of use thereofVERACYTE INC·Filed 2020·Application pending·0 cites
- 2865US2017145513A1Methods and compositions of molecular profiling for disease diagnosticsVERACYTE INC·Filed 2016·Application pending·0 cites
- 2964US2021079471A1Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional dataVERACYTE INC·Filed 2020·Application pending·0 cites
- 3064US2025308632A1Prognosis and treatment of molecular subtypes of prostate cancerVERACYTE INC·Filed 2023·Application pending·0 cites
- 3164US2016312307A1Methods and compositions of molecular profiling for disease diagnosticsVERACYTE INC·Filed 2016·Application pending·0 cites
- 3264US2016312308A1Methods and compositions of molecular profiling for disease diagnosticsVERACYTE INC·Filed 2016·Application pending·0 cites
- 3364US2021040562A1Methods for evaluating lung cancer statusVERACYTE INC·Filed 2020·Application pending·0 cites
- 3464US2016312306A1Methods and compositions of molecular profiling for disease diagnosticsVERACYTE INC·Filed 2016·Application pending·0 cites
- 3564US2016312305A1Methods and compositions of molecular profiling for disease diagnosticsVERACYTE INC·Filed 2016·Application pending·0 cites
- 3664US2021355524A1Methods for Nucleic Acid SequencingVERACYTE INC·Filed 2021·Application pending·0 cites
- 3763US2020332368A1Nano46 genes and methods to predict breast cancer outcomeVERACYTE INC·Filed 2020·Application pending·0 cites
- 3863US2014349864A1Methods and compositions of molecular profiling for disease diagnosticsVERACYTE INC·Filed 2013·Application pending·0 cites
- 3962US2024071622A1Clinical classifiers and genomic classifiers and uses thereofVERACYTE INC·Filed 2023·Application pending·0 cites
- 4061US2017247759A1Biomarkers for diagnosis of lung diseases and methods of use thereofVERACYTE INC·Filed 2016·Application pending·0 cites
- 4161US2024209449A1Methods and systems to identify a lung disorderVERACYTE INC·Filed 2023·Application pending·0 cites
- 4260US2013150257A1Methods and compositions for sample identificationVERACYTE INC·Filed 2012·Application pending·0 cites
- 4357US2017335396A1Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional dataVERACYTE INC·Filed 2015·Application pending·0 cites
- 4456US2025263795A1Methods for classification of tissue samples as positive or negative for cancerVERACYTE INC·Filed 2025·Application pending·0 cites
- 4556US2022148677A1Methods and systems for detecting genetic fusions to identify a lung disorderVERACYTE INC·Filed 2021·Application pending·0 cites
- 4655US12297505B2Algorithms for disease diagnosticsVERACYTE INC·Filed 2021·Granted May 13, 2025·0 cites·25 claims
- 4753US2020232046A1Genomic sequencing classifierVERACYTE INC·Filed 2020·Application pending·0 cites
- 4851US2025305051A1Systems and methods of diagnosing idiopathic pulmonary fibrosisVERACYTE INC·Filed 2025·Application pending·0 cites
- 4951US2022084632A1Clinical classfiers and genomic classifiers and uses thereofVERACYTE INC·Filed 2020·Application pending·0 cites
- 5050US2013231258A1Methods and Compositions for Classification of SamplesVERACYTE INC·Filed 2012·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →